WidePoint Corporation announced it will hold a conference call on November 12, 2026, at 4:30 p.m. ET to discuss its financial results for the third quarter ended September 30, 2026. The company will release its earnings report before the call, which will include a Q&A session with management. This event allows investors to gain insights into WidePoint's recent performance and outlook. The call will be accessible via phone and webcast, with a replay available until November 26, 2026.
WidePoint's upcoming Q3 2026 conference call is set for November 12, 2026. For readers following Technology-sector stocks on Pluang, here is the market snapshot as of Oct 29, 2026 19:13 WIB: out of 150 priced US tech stocks, 21 rose and 127 fell. Notable movers include NBIS at USD 169.30 with a 1-day change of -7.15%, OKTA at USD 206.95 down 7.06% but with 100% buy order activity, and CRWD at USD 247.95 down 7.02% with 74% sell order activity. Typical hold times range from 26 to 98 days among these stocks.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
